Tags |
|
|
Links |
|
|
Main Subject - Innovation and Organisational Networks
Typically an organisation chart shows control or seniority, it does not show how the organisation actually works. On a daily basis people comm
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
unicate with each other, give advice and provide support for each other. These factors are mirrors for the organisational culture that exists
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
and hence a determining factor in the ability of an organisation to innovate. It would therefore be useful to have a measure of the extent of
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
he advice, trust and communications networks.
For a simple case each individual can be given a diagram of their whole organisation or team an
For a simple case each individual can be given a diagram of their whole organisation or team an
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
d asked to draw on the links for each of the three networks mentioned. This could prove cumbersome for larger groups and so it might be suffic
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
ient to determine a) the number of colleagues that an individual communicates with regularly and b) the number of other individuals that they
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
ave in each of their networks. All 3 types of network have a part to play, however if they are not well aligned or differ significantly from t
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
he organisation chart then major problems are likely to exist. Further problems may occur if they are not evenly distributed or there are sign
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
ificant bottlenecks. This data can also be used in other ways e.g. if you are considering using a particular individual as a change agent, mak
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
sure that they figure in most peoples’ trust and advice networks!
Communications Network - consider the largest group of pe
Communications Network - consider the largest group of pe
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
ople that an individual communicates with on a daily basis. Such communications can be written, verbal or electronic. It is also useful to ide
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
ntify if individuals communicate with people outside of their normal working groups and whether they have any formal responsibility for doing
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
o. A network such as this carries significant amounts of traffic, some of it idle chat. However, it is often the case that random events withi
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
n this network stimulate significant innovation events.
Trust Network - within any organisation there are networks of people
Trust Network - within any organisation there are networks of people
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
with whom others are willing to share political information, company secrets or provide support in a crisis. A trust network is thus a very i
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
portant part of an organisation, particularly in the areas of motivation and morale. Problems here are indicative of trouble ahead if it has n
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
ot already surfaced. Symptoms may occur during times of great change e.g. merger, takeover and redundancy or as a result of years of neglect.
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
In all cases, innovation (which relies on intrinsic motivation) will suffer.
Advice Network - an individual's advice network
Advice Network - an individual's advice network
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
consists of those whom they give advice to and receive advice from. This is restricted to technical advice or advice on solving problems and i
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
s not concerned with personal problems. It is this network that carries the knowledge that is concerned with solving crucial business dilemmas
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.mainsubjects.org.ua/article/31844/mainsubjects-Innovation-and-Organisational-Networks.html">Innovation and Organisational Networks</a>
BB link (for phorums):
[url=http://www.mainsubjects.org.ua/article/31844/mainsubjects-Innovation-and-Organisational-Networks.html]Innovation and Organisational Networks[/url]
Related Articles:
Become a Storyteller Not an Advertiser and Watch Your Traffic Increase
Do I Really Need To Include Cover Letters With My Resumes When Applying For Jobs?
A Look at Industrial Air Compressors
Bookmark it:
|